Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IPR-Enhancing EU-Mercosur Trade Talks Set To Resume After Stalling

Executive Summary

The European Commission expects talks will resume in a matter of weeks for an EU-Mercosur trade deal, which would increase intellectual property rights protection for originator medicines in the Latin American markets.

You may also be interested in...



EU Under Fire Again For Pursuing Investor-State Dispute Settlement-like Mechanisms

The EU is once again facing criticism for its pursuit of investor-state dispute settlement-like mechanisms.

EU-Mercosur Trade Deal Could See Brazilian Drug Spending Soar

Free trade talks between the EU and South American countries in the Mercosur trade bloc are set to resume on Nov. 6 in Brasilia. Critics of the EU proposals on intellectual property say they would mean Brazil spending billions more on medicines.

Consultation To Help Determine Whether EU SPC Framework Fit For Purpose

The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates and patent research exemptions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS122281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel